Sánchez Navarro J J, del Pino Montes J, Martín Rodríguez M, García Talavera J R, Calvo Andrés J J, García Marín L J
Dpto. de Medicina, Hospital Clínico Universitario, Salamanca.
An Med Interna. 1990 Nov;7(11):561-4.
Increased levels of plasmatic calcitonin (PC) have been found in patients afflicted with liver cirrhosis (LC). Different circulating polypeptides of calcitonin with contrasting molecular weight (MW) have been observed by way of several methods of identification. The aim of our study is identify these types of PC in patients afflicted with LC, using a gel chromatography technique, comparing them with those obtained from patients with thyroid medullar carcinoma (TMC). A first PC peak with MW of 30,000 daltons (D) corresponding to macromolecular types of PC of LC was observed. Furthermore, a second peak of PC, corresponding to a synthetic human calcitonin and to monomers of PC in patients with TMC was noted. This indicates is a slight increase of monomeric PC in patients with LC, although its biological function is unknown.
肝硬化(LC)患者血浆降钙素(PC)水平升高。通过几种鉴定方法观察到了分子量(MW)不同的降钙素循环多肽。我们研究的目的是利用凝胶色谱技术鉴定LC患者中的这些PC类型,并将其与甲状腺髓样癌(TMC)患者的PC进行比较。观察到第一个PC峰,其MW为30,000道尔顿(D),对应于LC的大分子PC类型。此外,还注意到第二个PC峰,对应于合成人降钙素和TMC患者中的PC单体。这表明LC患者中单体PC略有增加,尽管其生物学功能尚不清楚。